Ginza ODA CLINIC
Provision of cutting-edge immunotherapy (NKM immune cell therapy), advanced regenerative medical technology, and cell banking services, offering innovative therapeutic methods and aesthetic medicine.
Type: Stem cell, Ainprose
Location: Tokyo
![Clinic Image 1](assets/images/ginzaoda1.png)
![Clinic Image 2](assets/images/ginzaoda2.png)
![Clinic Image 3](assets/images/ginzaoda3.png)
![Clinic Image 4](assets/images/ginzaoda4.png)
![Clinic Image 5](assets/images/ginzaoda5.png)
Director of Ginza ODA CLINIC
Dr. Osamu Oda, Director of Ginza Oda Clinic, is a specialist in preventive medicine with decades of experience across China, Korea, and Japan. Combining Eastern and Western medical knowledge, he is dedicated to reducing illnesses through proactive health management and fostering well-being for all.
![Director of Ginza ODA CLINIC](assets/images/ginzaoda-doctor.png)
Extensive Experience and Expertise
Dr. Osamu Oda, Director of Ginza Oda Clinic, combines decades of medical practice and research across China, South Korea, and Japan with a focus on preventive medicine. After earning degrees from Yanbian Medical College, Jilin Medical University, and Seoul Chung-Ang University, he honed his expertise in both Eastern and Western medical practices. His holistic approach emphasizes personalized, patient-centered care and innovative prevention strategies, blending traditional and modern medicine to enhance health and well-being.
Professional history
- Born in January 1954, Jilin Province, China.
- Graduated from Yanbian Medical College and Jilin Medical University.
- Worked at the Second Surgery Department of Antu County Hospital in Jilin Province.
- Focused on biochemical medical research at the Institute of Life Sciences, Jilin Medical University.
- Expanded his research horizons by enrolling in the Faculty of Medicine at Seoul Chung-Ang University in South Korea.
Treatments
Prices
※One of the risks associated with this therapy is that the administration of the stem cell culture supernatant may cause side effects such as temporary allergies.
※Stem cell culture supernatant is not a pharmaceutical product approved under the PMD Act.
※In Japan and other countries, there is no definitive information on the potential for serious risks associated with stem cell culture supernatant.
※There is no other approved pharmaceutical product in Japan with the same ingredients and functions as stem cell culture supernatant.
Clinic Information
Name of Medical Institution
Ginza ODA CLINIC
Address
Okura Main Building 11FF
2-6-12 Ginza, Chuo-ku,
Tokyo 1040061, Japan
Nearest Station
Ginza, Ginza-ichome, Yurakucho
Operation Hours
Mon-Fri 10:00-13:00/14:00-19:00
Closed: Saturday • Sunday • National Holidays